A new approach to curb binge eating may lower diabetes risk in young black women
NCT ID NCT06848244
First seen Aug 25, 2026 · Last updated Aug 26, 2026 · Updated 1 time
Summary
This study tests two behavioral programs—Appetite Awareness Training and the Diabetes Prevention Program—to see if they can reduce binge eating and prevent weight gain in Black women aged 18-25 who are at risk for type 2 diabetes. Participants will attend 16 core sessions over six months plus six maintenance sessions over a year. The goal is to lower diabetes risk by addressing binge eating, a key modifiable factor in this population.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Two behavioral programs: Appetite Awareness Training (AAT) and the Diabetes Prevention Program (DPP)
- What this could lead to
- If successful, this could point to an effective way to reduce binge eating and prevent type 2 diabetes in young Black women, helping to close health disparities.
- What could go wrong
- This is an early-stage trial with a relatively small group, so results may not apply broadly. The programs require active participation, and long-term success is uncertain.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 100 people
The number the study aims to enrol. It can still change while the study runs.
- Started
-
Jun 2025
- Expected to finish
-
Dec 2030
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 25 years
- Sex
-
Female participants only
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Black women * between 18-25 years of age * BMI ≥ 25 kg/m\^2 * At least one binge eating episode weekly * Prediabetic * Have access to a smartphone Exclusion Criteria: * Have no internet access * Currently type 2 diabetic * Currently pregnant * Are in substance use treatment * Have received prior or planned bariatric surgery
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Binge eating are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
UNC-Chapel Hill
Chapel Hill, North Carolina, 27599, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- The acute effects of an endurance exercise bout the gut microbiome and gut-derived metabolome in Women's distinct fitness and body mass indexes
- Cost-Effectiveness and implementation of integrated Diabetes-Oral health care in oman: a health belief Model-Based intervention to enhance clinical, behavioral, and exploratory oral microbiome in health system outcomes in type 2 diabetes
- Pilot study to evaluate the effect of nicotinamide riboside on immune activation in psoriasis
- The feasibility of electrical impedance tomography to guide non-invasive respiratory interventions in chronic respiratory disease
- Community engaged Alliance-Reimagined environments and systems together for outcomes georgia through research and evaluation for sustainability (RESTORES) - georgia CEAL RESTORES
- Can a new injection help tackle obesity? a trial puts it to the test